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Is the Cost the Reason for
Missing the ECG Advantages?*
Antonio Pelliccia, MD
Rome, Italy
In this issue of the Journal, Halkin et al. (1) describes the
rojected Medicare costs for electrocardiogram (ECG)-
ased screening in the population of high school and college
thletes in the United States.
Screening athletes and participants in organized compet-
tive sports for cardiovascular disease is universally consid-
red as a justifiable, necessary, and compelling initiative on
he basis of ethical, legal, and medical grounds. Indeed,
re-participation screening (PPS) is commonly viewed as an
mportant public health initiative (2). However, the best
trategy for PPS is still debated, in particular regarding the
mplementation of the 12-lead ECG, which has been
upported by the European Society of Cardiology Sport
ardiology, International Olympic Committee, and the
nternational Federation of Association Football (3,4), and
currently is rejected by the AHA (2,5).
See page 2271
The Halkin et al. paper (1) presents the ultimate evidence
against the implementation of the ECG, by showing that
projected costs will be prohibitive in the United States.
Based on Medicare’s list to compute the costs for diagnostic
testing needed on the estimated 8.5 million U.S. athlete
population over a 20-year period, the investigators reached
the conclusion that the cost per life saved would be largely
in excess of $10 million. Based on their computations, we
agree that cost for ECG-based PPS (i.e., at minimum $224
for history and physical exam, 39$ for ECG, totaling $263
in each athlete) is clearly prohibitive in the United States,
but most likely in all countries over the world.
We believe, however, that this way to assess the cost of
PPS is misleading. We do not argue that Medicare is the
current standard for pricing diagnostic testing in the United
States, but we do argue that the cost of PPS should be
computed by this approach. In our opinion, PPS (including
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procedure, and the cost should be computed as a package,
not for the individual tests.
Our belief is based on the following considerations:
1) PPS is a preventive medicine program that targets young
individuals, most of whom are healthy; 2) PPS is commonly
located out-of-hospital (e.g., in colleges and schools); and
3) PPS is performed by team physicians and does not
require cardiologists, except in a minority of athletes re-
ferred for a second opinion. Consequently, the PPS should
be priced as a package of preventive medicine program,
which is by far less expensive than pricing the individual
diagnostic testing.
For example, in Italy, where the screening program is
mandatory for athletes engaged in competitive sports (6),
he PPS fee is computed (as a package) at about 50 Euros
e.g., $60) per athlete. This modest price, based on the
greement between the Board of Sport Physicians and the
ederal government, is largely affordable for most Italian
thletes and is even refunded by the National Health System
or young individuals with very low income.
The rationale to implement a mandatory screening pro-
ram, which conveys an obligatory cost to citizens partici-
ating in sport, is based on the widely accepted perception
hat individuals engaged in competitive sport are exposed to
n increased risk (7) and, for this reason, deserve greater
ublic attention. Screening athletes, therefore, is not seen in
taly as a discriminatory policy targeting a subset of our
opulation, but as an expression of our attitude for preven-
ive medical programs, which are widely accepted and
conomically supported by the Italian population.
We acknowledge that reimbursement of PPS as a pre-
entive medicine program does not currently exist in the
edicare system, and this represents a major obstacle, in
ur opinion, to implementation of the ECG-based PPS.
egitimacy for PPS reimbursement with Medicare, how-
ver, will require a change in the cultural attitude and
urrent medical policy in the United States, where preven-
ive medicine programs are unlikely to be federally sup-
orted. Therefore, we acknowledge that most of the alleged
bstacles to implementing ECG-based PPS reflect the
ultural and social differences existing between our societies
ather than being rooted in economic reasons.
One major obstacle for physicians in the United States to
ccept the ECG-based PPS is, in our opinion, the justified
oncern for the legal consequences potentially related to
isinterpretation of the ECG. Exposure to dreadful con-
equences may paradoxically rise for the physician in cases of
ebated decisions aimed to prevent sudden death in a
usceptible individual (8).
U.S. physicians pay great attention to the appropriate
nterpretation of ECG in athletes, which sometimes present
hanges mimicking cardiac disease (9). Even though ECG
raining is a core part of medical education, the ability of
ost physicians in the United States to interpret correctly
11
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that a significant improvement of physicians’ accuracy may
occur by introducing standardized criteria to distinguish
normal from abnormal ECG patterns (10), and preliminary
evidence has been reported that this improvement occurs
regardless the physician’s specialty (and predominantly in
noncardiologists) (11). Therefore, we believe that team
physicians may be educated appropriately and become
totally capable of distinguishing normal from abnormal
ECG patterns in athletes. Therefore, in our opinion, ECG-
based PPS does not routinely require the expertise of
cardiologists, except in borderline and doubtful cases, which
represent a minority of the athlete population (12).
We believe that physician’s education is the key point to
make implementation of ECG-based PPS possible in the
United States. At present, “sport cardiology” is almost an
unknown subspecialty in the United States, and peculiarities
of evaluation of athletes presenting with ECG abnormalities
are (with a few remarkable exceptions) largely unknown to
the larger medical community. However, we see a number
of signals emerging within the U.S. society that testify an
increasing interest for a wider use of ECG in athletes’ care.
Several scientific initiatives have flourished in the recent
years that aim to understand the value of the novel Euro-
pean Society of Cardiology criteria to read ECG (10) when
applied to U.S. athlete population (13), and normal stan-
dards for interpretation of the ECG in the U.S. athletes,
derived from the long-standing athletes program imple-
mented at Stanford University, have been published (14).
However, in our opinion, a surprising gap exists between the
predominant academic positions that still emphasize obsta-
cles and limitations for ECG implementation and the
increasing expectation of the majority of professional cardi-
ologists and team physicians, who are exposed to difficult
decision-making regarding interpretation and management
of ECG abnormalities in athletes.
In conclusion, we believe that assessing the benefits of
ECG-based PPS uniquely in terms of lives per year saved
and the costs by pricing the individual diagnostic testing
according to Medicare is simplistic and misleading. Forgot-
ten benefits include, for example, individuals timely identi-
fied with cardiovascular abnormalities who will be treated
appropriately and avoid sudden death, as well as the several
disorders affecting the skeletal, ocular, and other noncardiac
systems, which do not convey risk for death and can be
appropriately treated. Eventually, PPS represents the occa-
sion for educational activities targeted to prevent metabolic
and cardiovascular disease in young athletes and their
families. On the other hand, costs of ECG-based PPS may
reasonably be lower than predicted here and might become
affordable even in the United States, according to the model
of package previously discussed.
Finally, it seems quite odd that PPS without ECG is still
advocated by the American Heart Association as the current
medical practice (2) despite being completely inefficient to
detect cardiac disease at risk (15). If the cost is the maincriterion, then the only wise decision is to abolish the
current screening program, which is costly and inefficient to
the scope.
On the other hand, if a screening program has to be
implemented, as suggested by the American Heart Associ-
ation (2), then the ECG should be part of this program,
based on the evidence that it substantially improves the
efficacy of the PPS (16) and at present is the best medical
practice for screening athletes (17).
We believe that competitive athletes (and their families)
should be informed regarding the limitations of history and
physical examination and should not be deprived of the
opportunity to be screened by ECG, if they choose to do it.
We also believe that high schools, colleges, and interna-
tional sport federations share the ethical obligation to ensure
that their young affiliates should be screened accordingly.
Reprint requests and correspondence: Dr. Antonio Pelliccia,
Institute of Sport Medicine and Science, Largo Piero Gabrielli 1,
00197 Rome, Italy. E-mail: antonio.pelliccia@coni.it.
REFERENCES
1. Halkin A, Steinvil A, Rosso R, Adler A, Rozovski U, Viskin S.
Preventing sudden death of athletes with electrocardiographic screen-
ing: what is the absolute benefit and how much will it cost? J Am Coll
Cardiol 2012;60:2271–6.
2. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations
and considerations related to preparticipation screening for cardio-
vascular abnormalities in competitive athletes: 2007 update: a
scientific statement from the American Heart Association Council on
Nutrition, Physical Activity, and Metabolism. Circulation 2007;115:
1643–55.
3. Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-
participation screening of young competitive athletes for prevention of
sudden death: proposal for a common European protocol. Consensus
Statement of the Study Group of Sport Cardiology of the Working
Group of Cardiac Rehabilitation and Exercise Physiology and the
Working Group of Myocardial and Pericardial Diseases of the
European Society of Cardiology. Eur Heart J 2005;26:516–24.
4. Ljungqvist A, Jenoure P, Engebretsen L, et al. The International
Olympic Committee (IOC) Consensus Statement on periodic health
evaluation of elite athletes March 2009. Br J Sports Med 2009;43:
631–43.
5. Maron BJ. National electrocardiography screening for competitive
athletes: feasible in the United States? Ann Intern Med 2010;152:
324–6.
6. Pelliccia A, Maron BJ. Pre-participation cardiovascular evaluation of
the competitive athlete: perspectives from the 30-year Italian experi-
ence. Am J Cardiol 1995;75:827–9.
7. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sport
activity enhance the risk of sudden death in adolescents and young
adults? J Am Coll Cardiol 2003;42:1959–63.
8. Maron BJ. Sudden death in young athletes: lessons from the Hank
Gathers affair. N Engl J Med 1993;329:55–7.
9. Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of
abnormal electrocardiographic patterns in trained athletes. Circulation
2000;102:278–84.
0. Corrado D, Pelliccia A, Heidbuchel H, et al., for the Section of Sports
Cardiology, European Association of Cardiovascular Prevention and
Rehabilitation. Recommendations for interpretation of 12-lead elec-
trocardiogram in the athlete. Eur Heart J 2010;31:243–59.
1. Drezner JA, Asif IM, Owens DS, et al. Accuracy of ECG interpre-
tation in competitive athletes: the impact of using standardized ECG
criteria. Br J Sports Med 2012;46:335–40.
2279JACC Vol. 60, No. 22, 2012 Pelliccia
December 4, 2012:2277–9 Cost and Missing the ECG Advantages12. Pelliccia A, Culasso F, Di Paolo F, et al. Prevalence of abnormal
electrocardiograms in a large, unselected population undergoing pre-
participation cardiovascular screening. Eur Heart J 2007;28:2006–10.
13. Baggish AL, Hutter AM Jr., Wang F, et al. Cardiovascular screening
in college athletes with and without electrocardiography: a cross-
sectional study. Ann Intern Med 2010;152:269–75.
14. Uberoi A, Stein R, Perez MV, et al. Interpretation of the electrocar-
diogram of young athletes. Circulation 2011;124:746–57.
15. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller
FO. Sudden death in young competitive athletes: clinical, demo-
graphic, and pathological profiles. JAMA 1996;276:199–204.16. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G.
Trends in sudden cardiovascular death in young competitive athletes
after implementation of a pre-participation screening program. JAMA
2006;296:1593–601.
17. Pelliccia A. The preparticipation cardiovascular screening of compet-
itive athletes: is it time to change the customary clinical practice? Eur
Heart J 2007;28:2703–5.
Key Words: athletes y electrocardiogram y screening y sports y
sudden death.
